您当前的位置：
首页 >
文章列表页 >
Characteristics and influential factors for irAEs in patients with liver cancer caused by tislelizumab
更新时间：2025-12-26

    • Characteristics and influential factors for irAEs in patients with liver cancer caused by tislelizumab

    • “The latest research has found that immune related adverse reactions caused by the use of Trastuzumab in liver cancer patients are mainly grade 1-2, mainly manifested as hematological toxicity and hepatotoxicity. Patients with liver cancer complicated with chronic hepatitis B have a higher risk of adverse reactions.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 24, Pages: 3107-3112(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.24.16    

      CLC： R969.3;R979.1

    • Received：22 June 2025，

      Revised：2025-11-18，

      Accepted：18 November 2025，

      Published：30 December 2025

    移动端阅览

  • LI Haiping,SHEN Mengru,WEI Tao,et al.Characteristics and influential factors for irAEs in patients with liver cancer caused by tislelizumab[J].ZHONGGUO YAOFANG,2025,36(24):3107-3112. DOI： 10.6039/j.issn.1001-0408.2025.24.16.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0